Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil effectively treats hair loss, especially androgenetic alopecia, but needs more research for better understanding.

Hair loss drugs like finasteride may cause lasting sexual and mood side effects, and more research is needed to understand these risks.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

Hair gels may cause split ends in children.

Old drugs can be used for new treatments, saving time and money, but there are challenges like needing more evidence and legal concerns.

Low-dose oral minoxidil is an effective and safe treatment for hair loss.

Using electronic health records can help identify drug side effects but has some limitations.

Patients and doctors find current hair loss treatments unsatisfying and believe involving patients in decisions improves results.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Dutasteride and finasteride have similar risk for osteoporosis and fractures in older men.

The FDA rejected a testosterone drug again due to safety concerns.

A woman with asthma improved from a severe fungal infection after treatment change, and most HIV-positive women in a UK study had low immune cell counts but were responding well to treatment.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

Pill splitting increased generic finasteride sales but didn't affect branded finasteride sales.

Digital video microscopy is a useful non-invasive tool for diagnosing non-scarring alopecia.

A new diagnostic tool for Vulvovaginal Lichen Planus is highly accurate, and updated treatments for various skin conditions, including melanoma and Hidradenitis Suppurativa, were discussed.

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

Remove inflamed cysts surgically, avoid topical antibiotics on wounds, treat skin and mouth conditions with specific medications, and address underlying causes of hair loss.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Women with schizophrenia on atypical antipsychotics are more likely to have polycystic ovarian syndrome (PCOS) than women without schizophrenia.

Some antidepressants can cause emotional numbness and other unusual side effects.

This special edition focuses on the unique aspects of treating skin conditions in women, including during pregnancy and in diverse populations like women of color and transgender patients.

The document concludes that hair loss in women is complex, often linked to aging, health conditions, and nutritional deficiencies, and emotional impacts should not be underestimated.

The 16-year-old girl with hair loss was successfully treated for alopecia areata, leading to significant hair regrowth.

The editorial concludes that while evidence-based medicine is crucial, doctors should also use their own experience and consider patient preferences in dermatology care.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

Treating chronic hand eczema costs about the same in statutory and occupational health insurances in Germany, but work-related cases may lead to higher indirect costs due to longer work absences.

Cataract surgery guidelines vary across Europe, and generic finasteride sales for hair loss have grown due to pill splitting.

Cataract surgery in Europe varies in frequency and cost between countries.